Pricing Log in Create free account
Friday 6 November 2026 Export DXCM’s income statement to Excel — free account

DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024.

Revenue
+11.2%
EPS
0.00%
Free cash flow
−52.9%
Total debt
+0.31%

Quarter to September 2026, against a year earlier

79.50 4.96 −5.87%
Market cap
$31.5B
P/E
32.6×
Fwd P/E
31.8×
Dividend yield
—
F-score
8/9
Altman Z
6.43
Beneish M
−2.70
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

DexCom, Inc. (DXCM) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, DexCom, Inc. (DXCM) trades at a EV/Sales of 6.2×. Over the past ten years it has ranged from 4.5× (November 2025) to 26.8× (November 2021); the current reading is higher than 9% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 5.6× (25.38%)
FY2024 7.4× (43.78%)
FY2023 13.3× (12.75%)
FY2022 15.2× (27.40%)
FY2021 20.9× 18.99%
FY2020 17.6× 33.27%
FY2019 13.2× 33.50%
FY2018 9.9× 48.33%
FY2017 6.7× (19.56%)
FY2016 8.3× (48.19%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 6.4× 22.71%
Jun 2026 5.2× 5.21%
Mar 2026 4.9× (11.19%)
Dec 2025 5.6× 0.37%
43 more quarters

Against its own ten years

Low 4.5× High 26.8×
Ten-year median 12.3×
Current reading's percentile 10

EV/Sales against peers

Company EV/Sales
SNN Smith & Nephew SNATS, Inc. compare 1.6×
PHG Koninklijke Philips N.V. compare 1.7×
GEHC GE HealthCare Technologies Inc. compare 2.1×
ZBH Zimmer Biomet Holdings, Inc. compare 3.2×
BSX Boston Scientific Corporation compare 3.6×
STE STERIS plc compare 4.2×
DXCM DexCom, Inc. 6.2×
EW Edwards Lifesciences Corporation compare 8.2×
GKOS Glaukos Corporation compare 18.8×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on DXCM